In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.

Sparfloxacin was more potent than other quinolones (tosufloxacin, lomefloxacin, ciprofloxacin, ofloxacin, fleroxacin, enoxacin, and norfloxacin) and as potent as minocycline and doxycycline in activity against Chlamydia trachomatis in vitro and in vivo. Sparfloxacin was more bactericidal than minocy...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Nakata, K, Maeda, H, Fujii, A, Arakawa, S, Umezu, K, Kamidono, S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189251/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1317145/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.1.188
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!